- Home
- OCGN vs GCO Comparison
OCGN vs GCO Comparison
Compare OCGN & GCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCGN
- GCO
- Stock Information
- Founded
- OCGN 2013
- GCO 1924
- Country
- OCGN United States
- GCO United States
- Employees
- OCGN N/A
- GCO N/A
- Industry
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- GCO Clothing/Shoe/Accessory Stores
- Sector
- OCGN Health Care
- GCO Consumer Discretionary
- Exchange
- OCGN Nasdaq
- GCO Nasdaq
- Market Cap
- OCGN 205.2M
- GCO 238.4M
- IPO Year
- OCGN N/A
- GCO N/A
- Fundamental
- Price
- OCGN $0.84
- GCO $21.29
- Analyst Decision
- OCGN Strong Buy
- GCO Hold
- Analyst Count
- OCGN 3
- GCO 2
- Target Price
- OCGN $6.00
- GCO $23.50
- AVG Volume (30 Days)
- OCGN 4.8M
- GCO 203.8K
- Earning Date
- OCGN 05-09-2025
- GCO 06-04-2025
- Dividend Yield
- OCGN N/A
- GCO N/A
- EPS Growth
- OCGN N/A
- GCO N/A
- EPS
- OCGN N/A
- GCO N/A
- Revenue
- OCGN $4,522,000.00
- GCO $2,325,062,000.00
- Revenue This Year
- OCGN N/A
- GCO $1.67
- Revenue Next Year
- OCGN N/A
- GCO $1.61
- P/E Ratio
- OCGN N/A
- GCO N/A
- Revenue Growth
- OCGN N/A
- GCO 0.02
- 52 Week Low
- OCGN $0.52
- GCO $16.19
- 52 Week High
- OCGN $1.98
- GCO $44.80
- Technical
- Relative Strength Index (RSI)
- OCGN 56.85
- GCO 47.18
- Support Level
- OCGN $0.64
- GCO $20.57
- Resistance Level
- OCGN $0.81
- GCO $22.00
- Average True Range (ATR)
- OCGN 0.09
- GCO 0.87
- MACD
- OCGN 0.00
- GCO -0.12
- Stochastic Oscillator
- OCGN 53.30
- GCO 17.52
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
About GCO Genesco Inc.
Genesco Inc. sells footwear, headwear, sports apparel, and accessories through four main segments. The Journeys Group generates the highest revenue, encompassing the Journeys, Journeys Kidz, and Little Burgundy brands, along with e-commerce and catalog sales. The Schuh Group targets teenagers and young adults aged 16 to 24, focusing on casual and athletic footwear. The Johnston & Murphy Group operates retail shops and factory stores across the United States. Finally, the Genesco Brands Group designs and sources licensed footwear for brands like Levi's, Dockers, and G.H. Bass.